Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Prostate cancer is one of the most common malignancies in men and exhibits substantial clinical heterogeneity. A considerable proportion of patients experience biochemical recurrence after primary treatment, and metabolic reprogramming has emerged as an important driver of tumor progression and tumor microenvironment remodeling. METHODS: Metabolism-related genes (MRGs) were systematica...
PURPOSE: Our purpose was to develop and validate an integrated clinical deep learning radiomics (DLR) nomogram for differentiation of fat-poor angiomyolipoma (fp-AML) from clear-cell renal cell carcinoma (ccRCC) in diagnostically challenging cases and to systematically compare spatial-input strategies for optimal model performance. METHODS: This retrospective study enrolled 469 patients with patho...
This is a narrative review that provides a perspective on the recent advances in deep learning (DL)-driven multimodal data integration for lung cancer...
Chronic lymphocytic leukaemia (CLL) presents considerable therapeutic obstacles due to the development of treatment-resistant disease, especially with...
BACKGROUND: As oncology workflows integrate increasingly autonomous artificial intelligence (AI) agents, health systems face uncertainty regarding ope...
INTRODUCTION: Deep learning image reconstruction (DLIR) has been incorporated into dual-energy CT (DECT) to improve image quality. However, its applic...
Acute Myeloid Leukemia predominantly affects older adults, who often present with comorbidities, functional impairment, and frailty, limiting eligibil...
OBJECTIVE: To develop and validate a deep learning model integrating multi-modal ultrasound information from B-mode ultrasound (BMUS) and strain elast...
Despite thorough characterizations of cellular compositions within the breast tumor microenvironment (TME), their implications for disease progression...
This study presents the development and evaluation of a novel lead-free composite for radiation shielding, designed using an artificial neural network...
For monitoring the progression of the disease and the efficacy of treatment, it is essential to segment the brain tumor. The majority of the available...
Cancer immunotherapy targeting the PD-1/PD-L1 pathway has transformed modern oncology; however, developing small-molecule inhibitors as viable alterna...
Sex and gender represent critical yet underutilized precision biomarkers in oncology, influencing cancer incidence, progression, treatment response, a...
Molecular heterogeneity in head and neck squamous cell carcinoma (HNSCC) is well recognized, yet existing subtype frameworks remain largely descriptiv...
OBJECTIVE: To develop and validate a clinical-radiomics model based on multiparametric MRI for differentiating solitary primary spinal tumors from sol...
BACKGROUND: Artificial intelligence (AI) is increasingly recognized as a valuable tool for the early detection and prognosis of oral cancer, addressin...
BACKGROUND: Cell-cell communication (CCC) mediated by ligand-receptor (L-R) interactions is fundamental to deciphering tissue development and disease ...
BACKGROUND: Predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy (NACI) in locally advanced gastric cancer (LAGC) ...
Cancer stem cells (CSCs) drive tumour initiation, progression, metastasis, and therapy resistance through their remarkable plasticity, enabling dynami...
Accurate prediction of fire consequences is fundamental to process safety management and quantitative risk assessment in the chemical process industri...